Neurodiagnostics Market
  • ID: 1312
  • February 13, 2019
  • 110 pages
  • Infoholic Research

Global Neurodiagnostics Market Forecast up to 2025
[110 pages report] This market research report includes a detailed segmentation of the global neurodiagnostics market by technology [neuroimaging technologies (computed tomography (CT), nuclear medicine imaging (NMI), magnetic resonance imaging (MRI), electroencephalography (EEG), magnetoencephalography (MEG), near infrared spectroscopic imaging (NIRS) and voxel-based morphometry), in vitro diagnostics, and neuroinformatics] and by regions [North America, Europe, APAC and RoW].
Overview of the Global Neurodiagnostics Market Research
Infoholic’s market research report predicts that the global neurodiagnostics market will grow at a CAGR of 7.5% during the forecast period. The market has witnessed steady growth in the past few years, and the development in technology with the introduction of advanced products has increased the acceptance of neurodiagnostics products in the market. The market is fueled by the growing adoption of novel diagnostics technologies, upsurge in the number of patients with neurological diseases, and increasing aging population.

Imaging and in vitro diagnostics are the most widely used technologies for the diagnosis of mental health disorders. This particular field is getting revolutionized with the advancement in technology. Globally, there are around dozens of 7-T machines in research labs, and the first 7-T model was cleared for clinical use in 2018. Vendors are focusing on new product launches and targeting toward end user's perspective. The revenue is generated from the key players operating in this field, and few of them include GE Healthcare, Philips Healthcare, Siemens Healthineers, Canon Medical Systems Corporation, Hitachi Medical Corporation, and Nihon Kohden Corporation.
According to Infoholic Research analysis, North America accounted for the largest share of the global neurodiagnostics market in 2018 and will retain a high position during the forecast period. The region has the highest percentage of the geriatric population with a growing prevalence of neural diseases such as Parkinson disease, epilepsy, migraine, and stroke. Further, the availability of advanced technologies is driving the market growth in North America. The Asia Pacific region is expected to witness the fastest growth rate due to the increasing patient pool, growing awareness among patients, and rising healthcare expenditure.
By Technology:
• Neuroimaging Technologies
 Computed Tomography (CT)
 Nuclear Medicine Imaging (NMI)
 Magnetic Resonance Imaging (MRI)
 Electroencephalography (EEG)
 Magnetoencephalography (MEG)
 Near-infrared Spectroscopic Imaging (NIRS)
 Voxel-based Morphometry (VBM)
• In Vitro Diagnostics
• Neuroinformatics
In 2018, the neuroimaging technologies segment occupied the largest share and is expected to remain the same during the forecast period. Among various neuroimaging technologies, CT and MRI are the two key imaging modalities commonly used to identify brain anomalies. The neuroinformatics segment is anticipated to grow at a high CAGR during the forecast period.
By Regions:
• North America
• Europe
• APAC
• ROW
The market is dominated by North America, followed by Europe and Asia Pacific. The US occupied the dominant share in North America due to the rapid adoption of new and advanced diagnostic technologies.
Neurodiagnostics Market Research Competitive Analysis – The global neurodiagnostics market has massive growth opportunities in both developed and developing regions. The advancements and upgradation of technology will increase the competition among vendors. Many vendors are focusing on developing innovative products to strengthen their product portfolio that intensifies the market competition. In January 2018, Brain Vision Solutions launched LiveAmp 64, a high-density wireless EEG solution that can be used with a wide range of innovative electrode technologies and also, there is an easy upgrade path all the way from 8 to 64 channels. Nihon Kohden launched its airEEG WEE-1200 wireless EEG system in March 2018, and it is designed specifically for patient comfort and easy access to real-time patient data during long-term epilepsy monitoring.
GE Healthcare introduced its range of MRI contrast media products with the launch of macrocyclic agent Clariscan in Europe in March 2017. Canon Medical Systems launched its next-generation 80-row multi-slice CT scanner, Aquilion Prime SP, at UKRC in 2017. The company has also initiated collaborative research in March 2018 on the application of Artificial Intelligence (AI)-based technology in MR imaging, together with Kumamoto University and the University of Bordeaux. In addition, other leading players are focusing on investing heavily in R&D activities to develop new products to attain a maximum share in the market.
Key vendors:
• GE Healthcare
• Siemens Healthineers
• Philips Healthcare
• Canon Medical Systems Corporation
• Hitachi Medical Corporation
• Nihon Kohden Corporation
• Fonar Corporation
• Neusoft Medical Systems Co., Ltd.
• NeuroNexus Technologies, Inc.
• Lifelines Neurodiagnostic Systems, Inc.
• NeuroDx Development
• Bruker Corporation
• Plexon Inc
• Natus Medical Incorporated
Key competitive facts
• The market is highly competitive with all the players competing to gain market shares. Intense competition, rapid advancements in technology, frequent changes in government policies, and the prices are key factors that confront the market.
• The requirement of high initial investment, implementation, and maintenance cost in the market are also limiting the entry of new players.
Benefits – The report provides complete details about the usage and adoption rate of neurodiagnostics products. Thus, the key stakeholders can know about the major trends, drivers, investments, vertical player’s initiatives, and government initiatives toward the diagnostics segment in the upcoming years along with details of the pureplay companies entering the market. Moreover, the report provides details about the major challenges that are going to impact the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders in order to expand their business and capture the revenue in specific verticals, and to analyze before investing or expanding the business in this market.
Key Takeaways:
• Understanding the potential market opportunity with precise market size and forecast data.
• A detailed market analysis focusing on the growth of the neurodiagnostics industry.
• Factors influencing the growth of the neurodiagnostics market.
• In-depth competitive analysis of dominant and pure-play vendors.
• Prediction analysis of the neurodiagnostics industry in both developed and developing regions.
• Key insights related to major segments of the neurodiagnostics market.
• The latest market trend analysis impacting the buying behavior of the consumers.
Key Stakeholders

Table of Contents
1 Industry Outlook 10
1.1 Industry Overview 10
1.2 Total Addressable Market 10
1.3 Industry Trends 11
2 Report Outline 13
2.1 Report Scope 13
2.2 Report Summary 13
2.3 Research Methodology 14
2.4 Report Assumptions 14
3 Market Snapshot 16
3.1 Market Definition – Infoholic Research 16
3.2 Types of Neurological Diseases 16
3.3 Causes of Neurological Diseases 16
3.4 Signs of Neurological Disorders 17
3.5 Distinctive Neurological Procedures 17
3.6 Segmented Addressable Market 17
3.7 Key Trends in the Neurodiagnostics Market 18
3.8 Related Markets 19
3.8.1 Parkinson’s Diseases 19
3.8.2 Neurointerventional Devices 20
3.8.3 Neurosurgical Devices 22
4 Market Outlook 24
4.1 Market Segmentation 24
4.2 PEST Analysis 24
4.3 Porter 5(Five) Forces 25
5 Market Characteristics 27
5.1 DRO Analysis – Market Dynamics 27
5.1.1 Drivers 27
5.1.1.1 Increasing number of patients with neurological diseases 27
5.1.1.2 Increasing aging population 28
5.1.1.3 Growing adoption of novel diagnostic technologies 29
5.1.2 Opportunities 29
5.1.2.1 Upsurge in the introduction of new products and recent product approvals 29
5.1.2.2 Advancement in technology 30
5.1.3 Restraints 30
5.1.3.1 High cost of diagnosis 30
5.1.3.2 Lack of trained professionals 31
5.2 DRO – Impact Analysis 31
5.3 Key Stakeholders 32
6 Technologies: Market Size and Analysis 33
6.1 Overview 33
6.2 Neuroimaging 34
6.2.1 Computed Tomography 35
6.2.2 Magnetic Resonance Imaging 37
6.2.3 Nuclear Medicine Imaging 38
6.2.4 Near Infrared Spectroscopic Imaging 39
6.2.5 Electroencephalography 40
6.2.6 Magnetoencephalography 41
6.2.7 Voxel-based Morphometry 42
6.3 In Vitro Diagnostics 43
6.4 Neuroinformatics 44
7 Regions: Market Size and Analysis 46
7.1 Overview 46
7.2 North America 47
7.3 Europe 49
7.4 Asia Pacific 51
7.5 Rest of the World 52
8 Competitive Landscape 54
8.1 Overview 54
9 Vendors Profile 57
9.1 GE Healthcare 57
9.1.1 Overview 57
9.1.2 Business Units 61
9.1.3 Geographic Presence 63
9.1.4 Business Focus 63
9.1.5 SWOT Analysis 64
9.1.6 Business Strategies 64
9.2 Hitachi Medical Corporation 65
9.2.1 Overview 65
9.2.2 Business Units 67
9.2.3 Geographic Presence 69
9.2.4 Business Focus 69
9.2.5 SWOT Analysis 70
9.2.6 Business Strategies 70
9.3 Siemens Healthineers 71
9.3.1 Overview 71
9.3.2 Business Units 74
9.3.3 Geographic Presence 76
9.3.4 Business Focus 76
9.3.5 SWOT Analysis 77
9.3.6 Business Strategies 77
9.4 Philips Healthcare 78
9.4.1 Overview 78
9.4.2 Business Units 83
9.4.3 Geographic Presence 83
9.4.4 Business Focus 84
9.4.5 SWOT Analysis 85
9.4.6 Business Strategies 85
9.5 Canon Medical Systems Corp. 86
9.5.1 Overview 86
9.5.2 Business Units 88
9.5.3 Geographic Presence 89
9.5.4 Business Focus 90
9.5.5 SWOT Analysis 90
9.5.6 Business Strategies 91
9.6 Nihon Kohden Corporation 92
9.6.1 Overview 92
9.6.2 Business Units 94
9.6.3 Geographic Presence 95
9.6.4 Business Focus 96
9.6.5 SWOT Analysis 96
9.6.6 Business Strategies 97
10 Companies to Watch For 99
10.1 Bruker Corporation 99
10.1.1 Overview 99
10.1.2 Recent Developments 100
10.2 Fonar Corporation 101
10.2.1 Overview 101
10.2.2 Recent Developments 102
10.3 NeuroNexus Technologies 102
10.3.1 Overview 102
10.3.2 Recent Developments 103
10.4 Neusoft Medical Systems Co. Ltd. 103
10.4.1 Overview 103
10.4.2 Recent Developments 104
10.5 Plexon Inc. 104
10.5.1 Overview 104
10.5.2 Recent Developments 105
10.6 Lifelines Neurodiagnostics Systems Inc. 105
10.6.1 Overview 105
10.6.2 Recent Developments 106
10.7 Natus Medical 106
10.7.1 Overview 106
10.7.2 Recent Developments 107
10.8 NeuroDx Development 107
10.8.1 Overview 107
10.8.2 Recent Developments 108
11 Annexure 109
11.1 Abbreviations 109


TABLE 1 CLINICAL TRIALS OF NEUROINTERVENTIONAL DEVICES 22
TABLE 2 GLOBAL NEUROINFORMATICS MARKET REVENUE BY REGIONS, 2018–2025 ($MILLION) 47
TABLE 3 OTHER PROMINENT VENDORS OF NEURODIAGNOSTICS MARKET 55
TABLE 4 GE HEALTHCARE: OFFERINGS 57
TABLE 5 GE HEALTHCARE: RECENT DEVELOPMENTS 58
TABLE 6 HITACHI MEDICAL CORPORATION: OFFERINGS 65
TABLE 7 HITACHI MEDICAL CORPORATION: RECENT DEVELOPMENTS 66
TABLE 8 SIEMENS HEALTHINEERS: PRODUCT OFFERINGS 71
TABLE 9 SIEMENS HEALTHINEERS: RECENT DEVELOPMENTS 72
TABLE 10 PHILIPS HEALTHCARE: PRODUCT OFFERINGS 78
TABLE 11 PHILIPS HEALTHCARE: RECENT DEVELOPMENTS 79
TABLE 12 CANON MEDICAL SYSTEMS CORP.: PRODUCT OFFERINGS 86
TABLE 13 CANON MEDICAL SYSTEMS CORP.: RECENT DEVELOPMENTS 86
TABLE 14 NIHON KOHDEN CORPORATION.: PRODUCT OFFERINGS 92
TABLE 15 NIHON KOHDEN CORPORATION: RECENT DEVELOPMENTS 92
TABLE 16 BRUKER CORPORATION: SNAPSHOT 99
TABLE 17 FONAR CORPORATION: SNAPSHOT 101
TABLE 18 NEURONEXUS TECHNOLOGIES: SNAPSHOT 102
TABLE 19 NEUSOFT MEDICAL SYSTEMS CO., LTD.: SNAPSHOT 103
TABLE 20 PLEXON INC.: SNAPSHOT 104
TABLE 21 LIFELINES NEURODIAGNOSTICS SYSTEMS, INC.: SNAPSHOT 105
TABLE 22 NATUS MEDICAL: SNAPSHOT 106
TABLE 23 NEURODX DEVELOPMENT: SNAPSHOT 107


Charts
CHART 1 RESEARCH METHODOLOGY OF GLOBAL NEURODIAGNOSTICS MARKET 14
CHART 2 GLOBAL NEURODIAGNOSTICS MARKET REVENUE, 2018–2025 ($MILLION) 18
CHART 3 GLOBAL NEURODIAGNOSTICS MARKET BY SEGMENTATION 24
CHART 4 PEST ANALYSIS OF GLOBAL NEURODIAGNOSTICS MARKET 24
CHART 5 PORTER 5 FORCES ON GLOBAL NEURODIAGNOSTICS MARKET 25
CHART 6 MARKET DYNAMICS – DRO ANALYSIS 27
CHART 7 DRO – IMPACT ANALYSIS OF GLOBAL NEURODIAGNOSTICS MARKET 31
CHART 8 KEY STAKEHOLDERS 32
CHART 9 GLOBAL NEURODIAGNOSTICS MARKET BY TECHNOLOGY SEGMENTATION, 2018 (%) 33
CHART 10 GLOBAL NEURODIAGNOSTICS MARKET BY TECHNOLOGY SEGMENTATION, 2025 (%) 33
CHART 11 GLOBAL NEUROIMAGING MARKET FORECAST, 2018–2025 ($MILLION) 35
CHART 12 GLOBAL COMPUTED TOMOGRAPHY MARKET FORECAST, 2018–2025 ($MILLION) 36
CHART 13 GLOBAL MAGNETIC RESONANCE IMAGING MARKET FORECAST, 2018–2025 ($MILLION) 37
CHART 14 GLOBAL NUCLEAR MEDICINE IMAGING MARKET FORECAST, 2018–2025 ($MILLION) 38
CHART 15 GLOBAL NUCLEAR INFRARED SPECTROSCOPIC IMAGING MARKET FORECAST, 2018–2025 ($MILLION) 40
CHART 16 GLOBAL ELECTROENCEPHALOGRAPHY MARKET FORECAST, 2018–2025 ($MILLION) 41
CHART 17 GLOBAL MAGNETOENCEPHALOGRAPHY MARKET FORECAST, 2018–2025 ($MILLION) 42
CHART 18 GLOBAL VOXEL BASED MORPHOMETRY MARKET FORECAST, 2018–2025 ($MILLION) 43
CHART 19 GLOBAL IN VITRO DIAGNOSTICS MARKET FORECAST, 2018–2025 ($MILLION) 44
CHART 20 GLOBAL NEUROINFORMATICS MARKET FORECAST, 2018–2025 ($MILLION) 45
CHART 21 GLOBAL NEUROINFORMATICS MARKET BY GEOGRAPHICAL SEGMENTATION, 2018 (%) 46
CHART 22 GLOBAL NEUROINFORMATICS MARKET BY GEOGRAPHICAL SEGMENTATION, 2025 (%) 46
CHART 23 NEURODIAGNOSTICS MARKET REVENUE IN NORTH AMERICA, 2018–2025 ($MILLION) 48
CHART 24 NEURODIAGNOSTICS MARKET REVENUE IN EUROPE, 2018–2025 ($MILLION) 50
CHART 25 NEURODIAGNOSTICS MARKET REVENUE IN ASIA PACIFIC, 2018–2025 ($MILLION) 51
CHART 26 NEURODIAGNOSTICS MARKET REVENUE IN REST OF THE WORLD, 2018–2025 ($MILLION) 52
CHART 27 GE HEALTHCARE: OVERVIEW SNAPSHOT 60
CHART 28 GE HEALTHCARE: BUSINESS UNITS 61
CHART 29 GE HEALTHCARE: GEOGRAPHIC PRESENCE 63
CHART 30 GE HEALTHCARE: SWOT ANALYSIS 64
CHART 31 HITACHI MEDICAL CORPORATION: OVERVIEW SNAPSHOT 66
CHART 32 HITACHI MEDICAL CORPORATION: BUSINESS UNITS 67
CHART 33 HITACHI MEDICAL CORPORATION: GEOGRAPHIC PRESENCE 69
CHART 34 HITACHI MEDICAL CORPORATION: SWOT ANALYSIS 70
CHART 35 SIEMENS AG: OVERVIEW SNAPSHOT 73
CHART 36 SIEMENS AG: BUSINESS UNITS 74
CHART 37 SIEMENS AG: GEOGRAPHIC PRESENCE 76
CHART 38 SIEMENS HEALTHINEERS: SWOT ANALYSIS 77
CHART 39 ROYAL PHILIPS.: OVERVIEW SNAPSHOT 82
CHART 40 ROYAL PHILIPS: BUSINESS UNITS 83
CHART 41 ROYAL PHILIPS: GEOGRAPHIC PRESENCE 83
CHART 42 PHILIPS HEALTHCARE: SWOT ANALYSIS 85
CHART 43 CANON MEDICAL SYSTEMS CORP.: OVERVIEW SNAPSHOT 87
CHART 44 CANON MEDICAL SYSTEMS CORP.: BUSINESS UNITS 88
CHART 45 CANON MEDICAL SYSTEMS CORP.: GEOGRAPHIC PRESENCE 89
CHART 46 CANON MEDICAL SYSTEMS CORP.: SWOT ANALYSIS 90
CHART 47 NIHON KOHDEN CORPORATION.: OVERVIEW SNAPSHOT 93
CHART 48 NIHON KOHDEN CORPORATION: BUSINESS UNITS 94
CHART 49 NIHON KOHDEN CORPORATION.: GEOGRAPHIC PRESENCE 95
CHART 50 NIHON KOHDEN CORPORATION.: SWOT ANALYSIS 96

None

GE Healthcare
Siemens Healthineers
Philips Healthcare
Canon Medical Systems Corporation
Hitachi Medical Corporation
Nihon Kohden Corporation
Fonar Corporation
Neusoft Medical Systems Co., Ltd.
NeuroNexus Technologies, Inc.
Lifelines Neurodiagnostic Systems, Inc.
NeuroDx Development
Bruker Corporation
Plexon Inc
Natus Medical Incorporated

Custom Research

Looking for more specific research study and analysis? Contact our Custom Research Team

Write to Custom Research Team